Immunomic Therapeutics, Inc. — Form D

Immunomic Therapeutics, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-15. The offering totals $10.0M, of which $4.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (44)

Showing 25 of 44 people.

NameRoleLocation
Yang Gon JinDirectorROCKVILLE, MD
Steve ParkDirectorROCKVILLE, MD
Robert AhlgrenDirectorROCKVILLE, MD
Dong-Gun KimDirectorROCKVILLE, MD
Dong-Gun KimExecutive OfficerROCKVILLE, MD
James WishartDirectorROCKVILLE, MD
Ki-Hong AhnDirectorROCKVILLE, MD
Matthew ChangDirectorROCKVILLE, MD
James ERIC WishartDirectorROCKVILLE, MD
C. ERIC WINZERDirectorROCKVILLE, MD
C. ERIC WINZERExecutive OfficerROCKVILLE, MD
Robert ERIC AhlgrenDirectorROCKVILLE, MD
Steve ERIC ParkDirectorROCKVILLE, MD
Ki-Hong ERIC AhnDirectorROCKVILLE, MD
Matthew ERIC ChangDirectorROCKVILLE, MD
Michael ERIC LackDirectorROCKVILLE, MD
Ronald ERIC ThiboutotDirectorROCKVILLE, MD
Yang Gon ERIC JinDirectorROCKVILLE, MD
Ronald P ThiboutotDirectorHarrisburg, PA
MICHAEL D LACKDirectorROCKVILLE, MD
ALEX S KIMDirectorROCKVILLE, MD
YANG-GON P JINDirectorROCKVILLE, MD
HYUK JOO P JEEDirectorROCKVILLE, MD
ARLO P MCGINNDirectorROCKVILLE, MD
Bruce F MacklerDirectorOntario, A6

Other filings by this issuer (12)

FiledFormOfferingSold
2025-06-02D$16.0M$6.5M
2024-04-10D$20.9M$3.0M
2021-01-14D/A$77.7M$77.7M
2020-02-26D$60.0M$10.0M
2018-08-03D$315K$315K
2014-10-15D/A$8.8M$6.8M
2014-10-15D/A$8.8M$6.8M
2014-04-24D$8.8M$1.0M
2013-06-12D$3.0M$2.7M
2013-06-12D$1.3M$1.1M
2013-06-12D/A$2.0M$1.6M
2012-03-05D$2.0M$1.1M

More